login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NAYA BIOSCIENCES INC (NAYA) Stock News
USA
- NASDAQ:NAYA -
US44984F4019
-
Common Stock
2.2
USD
+0.17 (+8.37%)
Last: 4/25/2025, 8:25:39 PM
2.34
USD
+0.14 (+6.36%)
After Hours:
4/25/2025, 8:25:39 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NAYA Latest News, Press Relases and Analysis
All
Press Releases
6 months ago - By: INVO Fertility, Inc.
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
6 months ago - By: Benzinga
- Mentions:
VNDA
CYH
ADAP
RLMD
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
6 months ago - By: Benzinga
- Mentions:
CISO
SBEV
ERIC
ALGM
...
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
6 months ago - By: NAYA Biosciences, Inc.
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
7 months ago - By: NAYA Biosciences, Inc.
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
8 months ago - By: NAYA Biosciences, Inc.
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
8 months ago - By: NAYA Biosciences, Inc.
NAYA Biosciences Announces Nomination of New Board Members
9 months ago - By: NAYA Biosciences, Inc.
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
10 months ago - By: NAYA Biosciences, Inc.
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
a year ago - By: NAYA Biosciences, Inc.
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
a year ago - By: NAYA Biosciences, Inc.
- Mentions:
INVO
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
a year ago - By: INVO Bioscience
- Mentions:
INVO
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
Please enable JavaScript to continue using this application.